F ollowing decades of speculation that changes in the regulation of genes could be a potent force in the evolution of form and function [1] [2] [3] , investigators have now empirically demonstrated the evolutionary importance of gene regulation across the tree of life [4] [5] [6] [7] [8] . Evolutionary changes in gene expression are primarily driven by mutations in non-coding DNA sequences, particularly those that bind transcription factors 9 . Accordingly, adaptive nucleotide substitutions at transcription factor binding sites (TFBSs) [4] [5] [6] [7] [8] [10] [11] [12] and gains and losses of TFBSs 13-21 both appear to make major contributions to the evolution of gene expression. These events are believed to modify rate-limiting steps during transcriptional activation 22 . In addition, transcriptional activity is correlated with various epigenomic and structural features, including post-translational modifications to core histones, the locations of architectural proteins such as CTCF and the organization of topological associated domains. As with TFBSs, these features display general conservation across species, yet exhibit some variation, which correlates with differences in gene expression 12, 20, [23] [24] [25] .
F ollowing decades of speculation that changes in the regulation of genes could be a potent force in the evolution of form and function [1] [2] [3] , investigators have now empirically demonstrated the evolutionary importance of gene regulation across the tree of life [4] [5] [6] [7] [8] . Evolutionary changes in gene expression are primarily driven by mutations in non-coding DNA sequences, particularly those that bind transcription factors 9 . Accordingly, adaptive nucleotide substitutions at transcription factor binding sites (TFBSs) [4] [5] [6] [7] [8] [10] [11] [12] and gains and losses of TFBSs [13] [14] [15] [16] [17] [18] [19] [20] [21] both appear to make major contributions to the evolution of gene expression. These events are believed to modify rate-limiting steps during transcriptional activation 22 . In addition, transcriptional activity is correlated with various epigenomic and structural features, including post-translational modifications to core histones, the locations of architectural proteins such as CTCF and the organization of topological associated domains. As with TFBSs, these features display general conservation across species, yet exhibit some variation, which correlates with differences in gene expression 12, 20, [23] [24] [25] .
Nevertheless, many open questions remain about the roles of TFBSs, chromatin organization and post-transcriptional regulation in the evolution of gene expression. Notably, the correlation between differences in transcription factor binding and differences in messenger RNA (mRNA) abundance is surprisingly low [26] [27] [28] . Possible reasons for this discordance include non-functional transcription factor binding 26, 27, 29 , compensatory gains and losses of TFBSs 16, [30] [31] [32] [33] , difficulties associating distal enhancers with target genes 34 and a dependency in transcription factor function on chromatin or chromosomal organization 35 . In addition, some changes in mRNA expression appear to be 'buffered' at the post-transcriptional level [36] [37] [38] . One reason why it has been difficult to disentangle these contributions to gene expression is that expression is typically measured in terms of the abundance of mRNA, which is subject to posttranscriptional processing 39 and therefore is an indirect measure of the transcription of genes by RNA polymerase II.
Here, we use precision run-on and sequencing (PRO-Seq) 40 to directly measure transcription and map the location of active regulatory elements, including distal enhancers 41 , in CD4 + T cells. We find that the rates at which regulatory elements are gained and lost over evolutionary time correlates with the distance to the nearest transcription start site (TSS) and the number of chromatin interactions detected in chromatin conformation capture data. Surprisingly, transcription levels in genes are more stable over evolutionary time when the gene is regulated by larger numbers of distal enhancers, yet in this case each enhancer exhibits more freedom to diverge. These findings suggest a critical role for redundancy and compensation in the evolution of ensembles of enhancers that jointly determine expression at target genes.
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collected under resting and activated conditions from three unrelated individuals representing each of three primate specieshumans, chimpanzees and rhesus macaques-spanning ~25-30 million years of evolution (Fig. 1a) . For a comparison with studies that focus on longer evolutionary branch lengths, we also collected resting samples from a single individual in each of two rodent species-the mouse and rat-which together serve as an outgroup to the primates (~80 million years of divergence). We used flow cytometry to validate the purity of isolated CD4
+ cells ( Supplementary Fig. 1 ). In addition, we used measurements of transcriptional activity of T cell subset markers for T-helper type 1 (Th1), Th2, Th17, T-regulatory and T-follicular helper cells to demonstrate that the population of CD4 + T cell subsets within the total CD4 + population was largely similar across species (Supplementary Fig. 2 ). PRO-Seq 40, 42 libraries were sequenced to a combined depth of ~1 billion uniquely mapped reads (~78-274 million per species) (Supplementary Table 1 ). Hierarchical clustering and principal component analysis of these data grouped the primate samples first by cell type or treatment condition and subsequently by species ( Fig. 1b and Supplementary Fig. 3 ).
To gain further insight into the evolution of the response to CD4
+ T cell stimulation, we compared transcriptional activity under resting and activated conditions within and between species. In humans, we found that phorbol 12-myristate 13-acetate (PMA) and ionomycin significantly altered the transcription levels of 6,940 (13%) GENCODE-annotated transcription units (P < 0.01, DESeq2 (ref. 43 ); Fig. 1c ). Parallel analyses in the chimpanzee and rhesus macaque revealed many similarities in transcriptional changes following PMA and ionomycin treatment ( Supplementary Fig. 4 ). We identified a core set of 3,157 transcription units that undergo evolutionarily conserved transcriptional changes in all three species following 30 min of PMA and ionomycin treatment, including many of the classical response genes (for example, interferon gamma (IFNG), tumour necrosis factor α (TNFα), interleukin-2 (IL2) and interleukin-2 receptor alpha (IL2RA)), as well as numerous novel genes and long intergenic non-coding RNAs. Active transcriptional regulatory + T cells were isolated from the blood or spleen of individuals from five vertebrate specieshuman, chimpanzee, rhesus macaque, mouse and rat. PBMCs, peripheral blood mononuclear cells; PMA, phorbol 12-myristate 13-acetate. b, Hierarchical clustering of PRO-Seq signal intensities in gene bodies groups CD4
+ T cell samples first by treatment condition and then by species. The colour scale represents Spearman's rank correlation between normalized transcription levels in active gene bodies. The coloured boxes (top) represent the species and treatment conditions of each sample. c, MA plot shows the log 2 -fold change following PMA and ionomycin (π ) treatment in human CD4
+ T cells (y axis) as a function of the mean transcription level in GENCODE-annotated genes (x axis). The red points indicate statistically significant changes (P < 0.01). Several classical response genes that undergo well-documented changes in transcript abundance following CD4 + T cell activation (for example, IL2, IFNG, TNFα and EGR3) are marked. d, Enrichment of transcription factor binding motifs in TREs that increase transcription levels following PMA and ionomycin treatment in the indicated species (n = 8,030 (human), 7,258 (chimpanzee), 7,967 (rhesus macaque)) compared with TREs whose transcription abundance does not change. The table shows the Bonferroni-corrected P value based on a Fisher's exact test (circle size) and the fold-enrichment over a group of unchanged background sequences (colour scale). Motif P values were calculated based on 100 distinct samples of the background distribution each with > 2,500 sites after correcting for differences in guanine-cytosine content (see Methods). Motif logos and the candidate transcription factor or motif identification number are shown. FDR, false discovery rate. e, Heat maps show the distribution of PRO-Seq (red and blue indicate transcription on the plus and minus strand, respectively), ChIP-Seq for H3K27ac, H3K4me1 and H3K4me3, and DNase-I-Seq signal intensity. Plots are centred on TREs predicted in untreated human CD4
+ T cells using dREG-HD (see Methods). All plots are ordered based on the maximum dREG score in the window.
elements (TREs) undergoing changes following PMA and ionomycin treatment were enriched for a similar set of transcription factor binding motifs across species, including those for nuclear factor-κ B (NF-κ B) and the activator protein-1 (AP-1) heterodimers FOS and JUN, which are known to be activated by canonical T cell receptor signalling (Fig. 1d) . Thus, the core regulatory principles responsible for T cell signalling and activation appear to remain broadly conserved across primate evolution.
Rapid evolutionary changes in transcribed enhancers. We used the detection of regulatory elements using GRO-Seq (dREG) software package 41 to identify 30,357 active TREs in human CD4 + T cells, based on patterns of enhancer-templated RNA or upstream antisense RNA transcription evident from PRO-Seq data. We classified these predicted TREs as either protein-coding promoters or candidate enhancers based on their proximity to gene annotations. The predicted TREs in each group were highly concordant with other marks of regulatory function in human CD4 + T cells used previously to define groups of candidate enhancers, including acetylation of histone 3 lysine 27 (H3K27ac), mono-and trimethylation of histone 3 lysine 4 (H3K4me1 and H3K4me3) and DNase-I-Seq signal ( Fig. 1e and Supplementary Note 1).
Extending our dREG analysis to untreated CD4 + T cells from additional species revealed 71,748 TREs that were active in untreated T cells in at least one species (ranging between 27,581 and 39,387 TREs in each species). We defined two types of change between species: (1) changes in the abundance of Pol II at TREs that were present across all species and (2) complete gains or losses in at least one species (see Supplementary Note 2 and Supplementary  Fig. 5 ). We found that 52% of distal TREs (henceforth referred to simply as 'enhancers') showed evidence of transcriptional changes in at least one of the three primate species and 81% showed changes at the longer evolutionary distance between primates and rodents ( Fig. 2a) , similar to recent observations in other systems 20, 44 . Next, we tested whether evolutionary changes in transcriptional activity correlate with the enrichment of other marks of active enhancers. Predicted lineage-specific human enhancers were enriched for both active and repressive enhancer marks (Fig. 2b and Supplementary Fig. 6 ). While apparent human gains were enriched for high levels of the active enhancer marker H3K27ac, sites with reduced transcriptional activity in humans showed much lower enrichments of H3K27ac. Furthermore, locations at which the dREG signal was completely lost in a human-specific fashion displayed levels of H3K27ac approaching those of randomly selected background sites (Fig. 2b) . Intriguingly, many of the losses on the human branch retained H3K4me1, which marks both active and inactive enhancers 45 , and these losses displayed higher levels of chromatin marks associated with transcriptional repression than a random background (Fig. 2b) , indicating that active ancestral primate enhancers often retain a 'poised' chromatin state in humans, despite losing both transcriptional activity and H3K27ac.
Transcriptional changes correlate with DNA sequence differences. To investigate whether changes in TRE activity are accompanied by changes in DNA sequence, we compared phyloP sequence conservation scores at transcriptionally conserved TREs with phyloP scores at TREs that display evolutionary changes in transcription. We restricted our sequence conservation analyses to TFBSs and selected a TFBS match threshold at which 60% of binding sites were expected to be bona fide TFBSs, as measured by ChIP-Seq (positive predictive value = 0.60; Supplementary Fig. 7 ). TFBSs found in transcriptionally conserved dREG sites showed a marked enrichment for higher phyloP scores relative to surrounding regions, indicating local sequence conservation (Fig. 3a) . In contrast, TFBSs in lineagespecific dREG sites had substantially reduced enrichments in phyloP scores (Fig. 3a, cyan and blue) . Notably, TFBSs in dREG sites lost on the human lineage showed enhanced conservation compared with those in human-specific gains. This observation is consistent with losses evolving under conservation in other mammalian species (which contribute to the phyloP scores) and gains emerging relatively recently. Each of these patterns was robust to corrections for potentially confounding differences in the distribution of sites, as well to choices of motif score thresholds ( Supplementary Fig. 8a ). Relaxing the motif score threshold to provide sensitivity for larger + T cells that are present in the human reference genome and are conserved across all species (blue), are not detectable and are therefore inferred as gains or losses (teal-white) or undergo significant changes (green) in at least one species, or fall in regions for which no orthologue occurs in at least one of the indicated genomes (pink). Inferred gains or losses are coloured according to the FDR-corrected P value associated with changes in RNA polymerase abundance (DESeq2). Plots labelled 'primate' illustrate the frequency of changes in a three-way comparison of human, chimpanzee and rhesus macaque focusing on the untreated condition, whereas those labelled 'mammal' summarize a five-way comparison also including rat and mouse. PMA and ionomycin (π ) treatment denotes a comparison between human untreated and PMA and ionomycin-treated CD4 Guide RNA target U p s t r e a m e n h a n c e r P r o m o t e r I n t e r n a l e n h a n c e r , gained (blue, n = 9,642), or lost (cyan, n = 11,632) on the human branch. Motifs (score > 10) are at least 100 bp from the nearest annotated exon. b, The genome browser track shows transcription near SGPP2 and FARSB in untreated (U) and π -treated CD4 + T cells isolated from the indicated primate species. PRO-Seq tracks show transcription on the plus (red) and minus (blue) strands in units of reads per kilobase per million mapped. Transcription units inferred from the PRO-Seq data are shown above the plot. The Green et al. 74 selective sweep scan track (top) represents the enrichment of derived alleles in the modern human where Neanderthal has the ancestral allele. Points below the line represent a statistically significant number of derived alleles in the modern human (the line indicates a z-score of -2). Net synteny tracks show the position of regions that have one-to-one orthologues in the chimpanzee and rhesus macaque genomes. c, Luciferase signal driven by the SGPP2 promoter or the internal enhancer in MCF-7 cells using DNA from each primate species. Bars show the mean fold-induction following 3 h of stimulation with TNFα (n = 3). Error bars represent s.e.m. *P < 1 × 10 -3 by a two-tailed t-test. d, Transcription of SGPP2 using primers targeting intron 1 following 0 or 40 min of TNFα treatment after silencing the indicated TRE using dCAS9-KRAB. Bars represent the median of three independent biological replicates of two guide RNAs targeting the promoter, three targeting the internal enhancer and four targeting the upstream enhancer. Error bars represent s.e. *P < × 10 -2 ; **P < 5 × 10 -3 by a two-tailed t-test. e, INSIGHT estimates of the fraction of nucleotides under selection (ρ ), segregating polymorphisms under weak negative selection (E(Pw)/kbp) or human nucleotide substitutions driven by positive selection (E(Dp)/kbp) in human populations in the indicated class of sites. Error bars represent one standard error. *P < 0.01 by a two-tailed chi-squared test (significant enrichment over background).
numbers of TFBSs at the expense of specificity revealed patterns of conservation that correlate with the information content of positions within the DNA sequence motif ( Supplementary Fig. 8b ), further supporting transcription factor binding as the functional property driving sequence conservation at these sites.
We searched for examples of DNA sequence differences that might be responsible for transcriptional changes following PMA and ionomycin treatment, hypothesizing that causal alleles might be characterized more easily than in the untreated condition (Fig. 1d) . In one example, we found nucleotide substitutions in three apparent NF-κ B binding sites in the proximal promoter and an internal enhancer of SGPP2 that correlate with differences in SGPP2 expression ( Fig. 3b and Supplementary Fig. 9 ). Two of these TFBSs were bound by NF-κ B in human cell lines according to ChIP-Seq data from ENCODE. Moreover, substitutions were either located in core positions of the DNA sequence motif (Fig. 3b) or were found to disrupt the same position in the motif as NF-κ B-binding quantitative trait loci ( Supplementary Fig. 9 ). All DNA sequence changes observed showed a trend towards higher predicted NF-κ B binding affinity in human than non-human primates. To test the hypothesis that the observed DNA sequence changes produced differential transcriptional activity, we cloned DNA from each primate species into a reporter vector driving luciferase activity in an MCF-7 cell model, which recapitulates the primary transcriptional features of the SGPP2 locus ( Supplementary Fig. 9 ). Differences in basal luciferase activity were generally concordant with those observed between species ( Supplementary Fig. 10 ). Moreover, both the proximal promoter of SGPP2 and the internal enhancer activated luciferase expression more strongly following NF-κ B activation with cloning of human DNA, but not with orthologous DNA from the other primates (Fig. 3c) .
To determine whether these TREs affect the expression of SGPP2 in its native genomic context, we silenced each TRE using clustered regularly interspaced short palindromic repeats (CRISPR) interference, which targets a catalytically dead CRISPR-associated protein 9 (CAS9) fused to the Krüppel-associated box repressor (dCAS9-KRAB), to specifically tri-methylate lysine 9 of histone 3 (H3K9me3). Three independent single-guide RNAs (sgRNAs) targeting the internal enhancer and two designed for the proximal promoter reduced SGPP2 transcription to 50-60% of its resting level (P = 1.5 × 10 -3 and 2.6 × 10 -2
, two-tailed t-test; Fig. 3d ), consistent with these TREs directly contributing to SGPP2 expression in MCF-7 cells. Three sgRNAs targeting the upstream enhancer also had a significant effect on SGPP2 expression (P = 1.8 × 10 -4 , twotailed t-test). Notably, the genome assemblies for the chimpanzee and rhesus macaque harbour deletions that affect multiple TFBSs in this upstream TRE ( Supplementary Fig. 9 ). However, although silencing individual enhancers reduced the transcription level of SGPP2 following NF-κ B activation, it was insufficient to completely abolish induction of SGPP2. Taken together, our findings show that at least two of the three TREs regulating SGPP2 drove expression patterns matching PRO-Seq data in a reporter assay, but none completely explained SGPP2 activation in situ. These observations suggest that that multiple causal substitutions in NF-κ B binding sites may work in concert to achieve human-specific activation of SGPP2.
Human-specific TREs appear to be evolving under positive selection. In many cases, as with SGPP2 (Fig. 3b) , we observed numerous nucleotide substitutions within individual or clustered TFBSs. These clusters of substitutions are highly unlikely to occur by chance and suggest that positive selection may have driven adaptation of these binding sites. To more directly measure the impact of positive selection, we used INSIGHT 46 to compare patterns of withinspecies polymorphism and between-species sequence divergence in TREs that had undergone human lineage-specific transcriptional changes. This analysis indicated that although dREG sites overall are most strongly influenced by weak negative selection (Fig. 3e) , TREs with lineage-specific transcriptional changes in humans are strikingly enriched for adaptive nucleotide substitutions (P < 0.01, INSIGHT likelihood ratio test; Fig. 3e ). We estimate a total of at least 121 adaptive substitutions since the human/chimpanzee divergence within TFBSs that undergo transcriptional changes in human CD4 + T cells. Despite limited power to detect the specific contributions of many individual transcription factors at our stringent motif match score threshold, we noted significant excesses of putatively adaptive substitutions in the predicted binding sites of several transcription factors, including motifs recognized by the forkhead box family, POU-domain-containing family and ELF/ETS family (Supplementary Fig. 11 ; P < 0.01, INSIGHT likelihood ratio test).
Rates of enhancer evolution vary with evidence for gene interactions. Despite an overall positive correlation between transcription at distal TREs and genes ( Fig. 4 and Supplementary Fig. 12 ; discussed in Supplementary Note 3), transcription at enhancers evolves rapidly and is frequently unaccompanied by transcriptional changes at nearby protein-coding genes. For example, CCR7 
transcription is highly conserved among both primate and rodent species despite several apparent changes in enhancer activity within the same locus (Fig. 5a ). One possible explanation for this disparity is that many predicted distal enhancers may actually have, at most, weak effects on the transcription of a target gene and therefore be under reduced evolutionary constraint. If this hypothesis is true, it should be possible to identify subsets of predicted distal enhancers that have stronger effects on transcription than others and are therefore more conserved over evolutionary time.
We searched for genomic features correlated with the conservation of transcription at enhancers, focusing on untreated CD4 + T cells in order to leverage the large amount of public data available for this cell type. Not surprisingly, one of the features most strongly correlated with transcriptional conservation at enhancers is the distance from the nearest TSS of a protein-coding gene (Fig. 5b) . More than half of the enhancers located within 10 kilobase pairs (kbp) of an annotated TSS are shared across all three primate species, whereas for distal enhancers located between 100 kbp and 1 megabase pair from a TSS that fraction drops to roughly one-third. This relationship is driven by lineage-specific gains or losses of enhancer activity and, to a lesser extent, by changes in TRE activity levels, rather than differences in the alignability of orthologous DNA ( Supplementary Fig. 13 ).
These simple distance-based observations, however, ignore the critical issue of chromatin interactions between enhancers and promoters. To account for such loop interactions, we extracted 6,520 putative TRE interactions from chromatin interaction analysis with paired-end tag sequencing (ChIA-PET) data recognizing loops marked with H3K4me2 in human CD4
+ T cells. We found that 55% of enhancers that participate in these loops were conserved between primate species compared with only 47% of non-looped enhancers ( Fig. 5c ; P = 5.6 × 10 -4 , Fisher's exact test). Moreover, higher transcriptional conservation at looped enhancers does not depend on the distance to the TSS. Parallel analysis of promoter-capture Hi-C data revealed that the strength of the chromatin interaction was correlated with evolutionary conservation of distal TREs, corroborating the result obtained using ChIA-PET (P < 1 × 10 -3 , bootstrap test). We observed similar levels of conservation at recently defined super-enhancers, although this conservation may simply reflect an enrichment for loop interactions (48% of TREs in super-enhancers loop according to ChIA-PET, compared with 15% of all TREs). Looped enhancers were also enriched for elevated phyloP scores relative to either non-looped enhancers or randomly selected DNA sequences (Supplementary Fig. 14 ; phyloP > 0.75; P < 2.2 × 10 -16 , Wilcoxon Rank sum test).
Enhancer-promoter interactions contribute to constraint on gene transcription levels. Another possible explanation for the differences in the rates of enhancer and promoter evolution is that stabilizing selection on transcription levels drives enhancers to compensate for one another as they undergo evolutionary flux. Examination of specific loci revealed several interesting examples where widely different strategies appeared to drive consistent levels of transcription in distinct combinations of species. In one example, SGPL1 is transcribed at similar levels in the chimpanzee and rhesus macaque, but both species activate transcription of SGPL1 in a distinct manner (Supplementary Fig. 15 ). We more commonly observed species-specific changes in enhancer activities at densely populated loci, as in the case of CCR7 (Fig. 5a ). 
We therefore hypothesized that redundancy in the set of enhancers associated with a target gene might enable compensation during enhancer evolution. Indeed, we found that evolutionary conservation of promoter TRE transcription is remarkably strongly correlated with the number of loop interactions a promoter has with distal sites (Fig. 6a, weighted Pearson's correlation = 0.87; P < 1 × 10 -3 , bootstrap test). A similar trend was observed between the number of loop interactions made by a target promoter and DNA sequence conservation in putative TFBSs at the promoter, although the effect was weaker and did not meet our criteria for statistical significance (Fig. 6b, weighted Pearson's correlation = 0.65; P = 0.07, bootstrap test).
How does redundancy in enhancers relate to the evolutionary conservation of the enhancers themselves? If redundant enhancers compensate for one another, perhaps each one will be less, rather than more, conserved when the associated promoters have larger numbers of loop interactions. To address this question, we examined the rate of conservation of looped enhancers as a function of the number of loops in which their gene-proximal partners participated. We found that DNA sequence conservation in putative TFBSs negatively correlates with the number of loops at the proximal end ( Fig. 6d ; weighted Pearson's correlation = -0.80; P = 2 × 10 -3 , bootstrap test). We noted a similar trend towards a negative correlation between the conservation of distal TRE transcription and the number of loop interactions (weighted Pearson's correlation = -0.67; P = 0.059, bootstrap test; Fig. 6c ). These results suggest that each associated distal TFBS is individually less essential at genes that have larger numbers of loop interactions with distal sites, and they are therefore consistent with a model in which such TFBSs are more freely gained and lost during evolution. Taken together, our results imply that distance, looping and redundancy of enhancers all contribute to constraints on the evolutionary rates of changes in gene transcription.
Discussion
Observations made recently across a number of biological systems [13] [14] [15] [16] [17] [18] [19] [20] [21] have demonstrated that changes in distal TREs arise surprisingly rapidly during the course of evolution, at much faster rates than evolutionary changes in protein-coding genes. However, the available data have not allowed the discordance in evolutionary rate to be explained. Do these disparities reflect compensation at the level of RNA stability, as has been observed at the translational level 36 , compensatory changes in transcriptional regulation, or are other factors involved? By making use of direct measurements of primary transcription and excluding the confounding effects of mRNA stability, our work strongly suggests that the effects of evolutionary changes in enhancers are buffered at the transcriptional level, most likely by compensatory changes at other enhancers.
Several lines of evidence in our study suggest that many apparent distal enhancers do not have a strong effect on gene expression, possibly explaining the rapid changes in TREs that are less likely to interact with protein-coding genes. In particular, we found that enhancer conservation is stratified by distance, in both onedimensional genomic coordinates (Fig. 5b ) and based on interactions in chromosome conformation capture data (Fig. 5c ), relative to genes. It is unlikely that these results can be explained by false positive or false negative TRE calls, as they are also supported by a more conservative approach based on raw PRO-Seq read counts (Supplementary Table 2 ). The higher levels of conservation observed for TREs that are found near genes suggest that these TREs have a disproportionately large effect on organism fitness and are therefore likely to more directly regulate the transcription of critical protein-coding genes.
An alternative (but not mutually exclusive) explanation for differences in the rates of evolution between enhancers and promoters is that enhancers frequently compensate for one another as they undergo evolutionary flux, whereas promoters are less labile. Our observations suggest that such compensatory evolution within ensembles of enhancers is a surprisingly widespread feature of mammalian genomes. We find that such compensation frequently arises at the locus level by changes in enhancers spread over genomic distances spanning tens to hundreds of kilobases and communicating through TRE-TRE loop interactions. This finding is supported by the strong correlation between the probability of conservation in the transcription of gene promoters (Fig. 6a) or their DNA sequences (Fig. 6b ) and the number of loop interactions with distal sites. These observations are also compatible with those made very recently in liver tissue 47 . In addition, we find a strong correlation in the opposite direction at the distal end of loops, where promoters that form more loop interactions have enhancers that are less, rather than more, conserved at the level of both transcription (Fig. 6c ) and the DNA sequence (Fig. 6d) . While this inverse correlation is at first counterintuitive, on further reflection it also supports the hypothesis of widespread enhancer compensatory turnover because it suggests lower conservation for those TFBSs that are part of large ensembles of regulatory elements than for those that act individually or in small numbers. This finding of widespread redundancy in the regulatory architecture of primate genes potentially has broad implications for our understanding of the general mode and tempo of regulatory evolution. 
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Committee guidelines. We obtained peripheral blood samples (60-80 ml) from healthy adult male humans, chimpanzees and rhesus macaques. Informed consent was obtained from all human subjects. To account for within-species variation in gene transcription, we used three individuals to represent each primate species. Blood was collected into purple-top EDTA tubes. Human samples were maintained overnight at 4 ºC to mimic shipping non-human primate blood samples. Blood was mixed 50:50 with phosphate buffered saline (PBS). Peripheral blood mononuclear cells were isolated by centrifugation (750 g) of 35 ml of blood:PBS over 15 ml Ficoll-Paque for 30 min at 20 ºC. Cells were washed three times in ice cold PBS. CD4 + T cells were isolated using CD4 microbeads (Miltenyi Biotech, 130-045-101 (human and chimp), 130-091-102 (rhesus macaque)). Up to 10 8 peripheral blood mononuclear cells were resuspended in binding buffer (PBS with 0.5% BSA and 2 mM EDTA). Cells were bound to CD4 microbeads (20 μ l of microbeads per 10 7 cells) for 15 min at 4 ºC in the dark. Cells were washed with 1-2 ml of PBS/BSA solution, resuspended in 500 μ l of binding buffer and passed over a MACS LS column (Miltenyi Biotech, 130-042-401) on a neodymium magnet. The MACS LS column was washed three times with 2 ml PBS/BSA solution before being eluted off the neodymium magnet. Cells were counted in a haemocytometer.
Isolation of CD4
+ T cells from mouse and rat. Spleen samples were collected from one male mouse (FVB) and one male rat (Albino Oxford) that had been sacrificed for Institutional Animal Care and Use Committee-approved research unrelated to the present study. Dissected spleen was mashed through a cell strainer using a sterile glass pestle and suspended in 20 ml Roswell Park Memorial Institute (RPMI) 1640 Medium. Cells were pelleted at 800 g for 3 min and resuspended in 1-5 ml of ACK Lysing Buffer for 10 min at room temperature to lyse red blood cells. RPMI 1640 Medium was added to a final volume 10 times that used for ACK lysis (10-40 ml). Cells were pelleted at 800 g for 3 min, counted in a haemocytometer and resuspended in RPMI 1640 Medium to a final concentration of 250,000 ml -1 .
CD4
+ T cells were isolated from splenocytes using products specific for mouse and rat (Miltenyi Biotech, 130-104-453 (mouse) and 130-090-319 (rat)) following instructions from Miltenyi Biotech and as described above.
T cell treatment and PRO-Seq library generation. CD4
+ T cells were allowed to equilibrate in RPMI 1640 Medium supplemented with 10% foetal bovine serum (FBS) for 2-4 h before starting the experiments. Primate CD4 + T cells were stimulated with 25 ng ml -1 PMA and 1 mM ionomycin (PI or π ) or vehicle control (2.5 μ l ethanol and 1.66 μ l dimethyl sulfoxide in 10 ml of culture media). We selected the minimum concentrations that saturate the production of IL2 and IFNG mRNA after 3 h of treatment. A 30 min treatment duration was selected after observing a sharp increase in the ChIP-quantitative polymerase chain reaction signal for RNA Pol II phosphorylated at serine 5 on the C-terminal domain on the IFNG promoter at 30 min. To isolate nuclei, we resuspended cells in 1 ml lysis buffer (10 mM Tris-Cl, pH 8, 300 mM sucrose, 10 mM NaCl, 2 mM MgAc2, 3 mM CaCl2 and 0.1% NP-40). Nuclei were washed in 10 ml of wash buffer (10 mM Tris-Cl, pH 8, 300 mM sucrose, 10 mM NaCl and 2 mM MgAc2) to dilute free nucleoside triphosphates. Nuclei were washed in 1 ml of storage buffer and subsequently resuspended in 50 μ l of storage buffer (50 ml Tris-Cl, pH 8.3, 40% glycerol, 5 mM MgCl2 and 0.1 mM EDTA), snap frozen in liquid nitrogen and kept for up to 6 months before making PRO-Seq libraries. PRO-Seq libraries were created exactly as described previously 40 . In most cases, we completed library preps with one member of each species (usually one human, one chimpanzee and one rhesus macaque) to prevent batch effects from confounding differences between species. Samples were sequenced on an Illumina Hi-Seq 2000 or NextSeq 500 system at the Cornell University Biotechnology Resource Center.
Mapping PRO-Seq reads. We mapped PRO-Seq reads using standard informatics tools. Our PRO-Seq mapping pipeline begins by removing reads that fail Illumina quality filters and trimming adaptors using cutadapt with a 10% error rate 48 . Reads were mapped with BWA 49 to the appropriate reference genome (either hg19, panTro4, rheMac3, mm10 or rn6) and a single copy of the Pol I ribosomal RNA transcription unit (GenBank identification: U13369.1). Mapped reads were converted to bigWig format for analysis using BedTools 50 and the bedGraphToBigWig programme in the Kent Source software package 51 . The location of the RNA polymerase active site was represented by the single base, the 3′ end of the nascent RNA, which is the position on the 5′ end of each sequenced read. After mapping reads to the reference genome, three samples (one human, U and PI, one chimpanzee, U and PI, and one rhesus macaque, U and PI) were identified as having poor data quality on the basis of the number of uniquely mapped reads and were excluded from downstream analysis.
Mapping 1:1 orthologues between different species. During all comparative analyses, the genomic coordinates of mapped reads, dREG scores and other parameters of interest were converted to the human assembly (hg19) using CrossMap 52 . We converted genomic coordinates between genome assemblies using reciprocal-best (rbest) nets 53 . These have the advantage that comparisons between species are constrained to 1:1 orthologues. This constraint on mapping is enforced by requiring each position to map uniquely in a reciprocal alignment between the human reference and the other species in the comparison. We downloaded rbest nets for hg19-mm10, hg19-panTro4 and hg19-rn6 from the University of California, Santa Cruz (UCSC) Genome Browser. We created rbest nets for hg19-rheMac3 using the doRecipBets.pl script provided as part of the Kent Source software package.
Analysis of TREs. Defining a consensus set of TREs.
We predicted TREs using dREG 41 separately in each species' reference genome. dREG uses a support vector regression model to score each site covered in a PRO-Seq dataset based on its resemblance to features associated with TSSs in a reference training dataset. The dREG model was trained to recognize DNase-I-hypersensitive sites that also show substantial evidence of GRO-cap data in six PRO-Seq or GRO-Seq datasets measuring transcription in resting K562 cells. dREG scores were computed in the reference genome of each species to provide as much information as possible on the native context of each locus. In all cases, we combined the reads from all individuals for each species to maximize power for the discovery of TREs. In the primate species, treated and untreated CD4 + T cells were analysed separately. We then defined a consensus set of TRE annotations, each of which bore the signature of an active TRE in at least one species and treatment condition. To define such a set, dREG scores were first converted to human reference genome (hg19) coordinates using CrossMap and the rbest nets. The advantage of converting dREG scores to the reference genome is that individual bases transfer more completely than genomic intervals using CrossMap and related tools. We then identified TREs in each species separately by thresholding the dREG scores. In all analyses, we selected a threshold of 0.3, which corresponds to a predicted FDR of < 7% compared with other sources of genomic data in human CD4
+ T cells. In addition, parallel analyses at separate thresholds (0.25 and 0.35) provided results that were in all cases consistent with those reported in the main manuscript (Supplementary Table 2 ). The set of overlapping TREs from each species was reduced to a single element containing the union of all positions covered by the set using bedops, and sites within 500 base pairs (bp) of each other were further merged. We assigned each putative TRE the maximum dREG score for each species and for each treatment condition.
Identifying differences in TREs between species.
Differences in TRE transcription in three-way (human-chimp-rhesus macaque) or five-way (human-chimp-rhesus macaque-mouse-rat) species comparisons were identified using a combination of heuristics and statistical tests. Starting with the consensus set of TREs in hg19 coordinates, we first excluded potential one-to-many orthologues by eliminating TREs that overlapped gaps in the rbest nets that were not classified as gaps in the standard nets. The remaining TREs were classified as unmappable when no orthologous position was defined in the rbest nets. Complete gains and losses were defined as TREs that were mappable in all species and for which the dREG score was less than 0.05 in at least one species and greater than 0.30 in at least one other species (see Supplementary Note 1). Gains and losses were assigned to a lineage based on an assumption of maximum parsimony under the known species phylogeny. We defined a set of TREs that displayed high-confidence changes in activity by comparing differences in PRO-Seq read counts between species using DESeq2 and thresholding at a 1% FDR (as described below). Changes in TRE activities were compared with histone modification ChIP-Seq, DNase-I-Seq and DNA methyl immunoprecipitation data from the Epigenome Roadmap project 54 .
TRE classification. For some analyses, TREs were classified as likely promoters or enhancers on the basis of their distance from known protein-coding gene annotations (GENCODE version 19). TRE classes of primary interest include (see also Supplementary Fig. 7 ): (1) promoters: near an annotated TSS (< 100 bp) and (2) enhancers: distal to an annotated TSS (> 5,000 bp)
Covariates that correlate with TRE changes. We compared the frequency at which evolutionary changes in transcription occur at TREs in a variety of different genomic contexts. We examined the rate of change as a function of distance from the nearest annotated TSS in GenCode version 19. TREs were binned by distance in increments of 0.02 on a log 10 scale and we evaluated the mean rate at which evolutionary changes in TRE transcription arose in each bin. We also compared the rate of changes in TRE transcription across a variety of functional associations, including loop interactions, within the same topological associated domain and in super-enhancers. H3K4me2 ChIA-PET data describing loop interactions were downloaded from the Gene Expression Omnibus database (GSE32677) (ref. 55 ) and the genomic locations of loops were converted from hg18 to hg19 coordinates using the liftOver tool. We also analysed a separate dataset profiling loop interactions based on promoter-capture Hi-C data in human CD4 + T cells taken from the supplementary materials of ref. 56 . Topological associated domains based on Hi-C data for GM12878 cells were also downloaded from the Gene Expression Omnibus database (GSE63525) (ref. 57 ). Super-enhancers in CD4 + T cells were taken from the supplementary data for ref. 58 . In all cases, we excluded sites with potential one-to-many orthology in any of the species included in the comparison (typically just the three primates). Potential one-to-many orthologues were defined based on differences in the standard and rbest nets for each species pair.
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Refining the location of active TREs using dREG-HD. During analyses of transcription factor binding motifs, we further refined the location of TREs to the region between divergent paused RNA polymerase using a strategy that we call dREG-HD (manuscript in preparation, preliminary version available at https:// github.com/Danko-Lab/dREG.HD). Briefly, we used an epsilon-support vector regression with a Gaussian kernel to map the distribution of PRO-Seq reads to smoothed DNase-I signal intensities. Training was conducted on randomly chosen positions within dREG peaks extended by 200 bp on either side. Selection of feature vectors was optimized based on Pearson correlation coefficients between the imputed and experimental DNase-I score over the validation set. PRO-Seq data were normalized by sequencing depth and further scaled such that the maximum value of any prediction dataset was within the ninetieth percentile of the training examples. We chose a step size to be 60 bp and extending 30 steps on each direction. The final model was trained using matched DNase-I and PRO-Seq data in K562 cells.
Next, we identified peaks in the imputed DNase-I hypersensitivity profile by fitting the imputed DNase-I signal using a cubic spline and identifying local maxima. We optimized two free parameters that control (1) the smoothness of spline curve fitting and (2) the threshold on the imputed DNase-I signal intensity. Parameters were optimized to achieve an appropriate trade-off between the FDR and sensitivity on the testing K562 dataset. Parameters were tuned using grid optimization over free parameters.
DNA sequence analysis. Finding candidate transcription factor binding motifs.
All motif analyses focused on 1,964 human transcription factor binding motifs from the Catalog of Inferred Sequence Binding Preferences database 59 clustered using an affinity propagation algorithm into 567 maximally distinct DNA binding specificities (see ref. 60 ). Scores, which reflect a log e odds ratio comparing each candidate motif model to a third-order Markov background model, were calculated using the RTFBSDB package 60 . We selected two separate motif thresholds for different analyses. Scores > 10 were used in analyses that mix multiple transcription factor binding motifs and strike a trade-off that focuses on minimizing false positives at the expense of sensitivity. We dropped the cutoff score to motifs > 8 in analyses that used individual motifs in order to increase the statistical power. For each of these thresholds, we estimated the mean genome-wide positive predictive values to be 0.60 and 0.38, respectively, for motif cutoffs of 10 and 8, by comparing motifs with ChIP-Seq peak calls in K562 cells. This represents a twofold improvement in performance over publicly available tools, even those using high-resolution DNase-I-seq data 61 ( Supplementary Fig. 8 ). Thus, our use of high-resolution PRO-Seq data and our improved computational toolkit achieved a highly respectable level of specificity on the difficult problem of TFBS prediction.
During comparative analyses, we scanned each primate reference genome separately with each motif to allow the detection of a putative binding site in any of the species included in the analysis and then moved scores to a human (hg19) reference genome using the CrossMap tool. We chose this strategy because changes in TRE activity may reflect changes in binding in any of the primate species. For example, human gains may be explained by either a new binding site for a transcriptional activator in the human genome or a loss in binding of a transcriptional repressor that was bound in both primate species.
Motif enrichment in TREs that change during CD4
+ T cell activation. Motifs enriched in up-or downregulated dREG-HD TREs during CD4 + T cell activation (P < 0.01) were selected using Fisher's exact test with a Bonferroni correction for multiple hypothesis testing. Up-or downregulated TREs were compared with a background set of > 2,500 guanine-cytosine content-matched TREs that do not change transcription levels following PMA and ionomycin treatment (log 2 -fold change < 0.5-fold in magnitude and P > 0.25) using the enrichmentTest function in RTFBSDB 60 . To test for motif robustness, the background resampling was repeated 100 times and motifs were selected that achieved a significant result in > 90% of cases.
DNA sequence conservation analysis. For our evolutionary conservation analysis, we used phyloP scores 62 based on the 100-way genome alignments available in the UCSC Genome Browser (hg19). In all cases, bigWig files were obtained from the UCSC Genome Browser and processed using the bigWig package in R. We represented evolutionary conservation as the mean phyloP score in each identified TFBS in the indicated set of dREG-HD sites.
Enrichment of DNA sequence changes in motifs. We identified single-nucleotide DNA sequence differences at sites at which two of three primate species share one base and the third species diverges. We intersected these species-specific divergences with matches to transcription factor binding motifs found within dREG-HD sites that undergo transcriptional changes between primate species. Because many motifs in the Catalog of Inferred Sequence Binding Preferences are similar to one another, we first partitioned the motifs using clustering (as described above) and examined enrichments at the level of these clusters. Motifs were ranked by the Fisher's exact test P value of the enrichment of species divergences in dREG-HD sites that changed transcription status (where changes in DNA sequence and transcription occurred on the same branch) to dREG-HD sites that did not change. We also computed the enrichment ratio, which we define as the number of species divergences in each transcription factor binding motif in dREG-HD sites that changed on the same branch normalized to the same statistic in sites that did not change.
INSIGHT analysis. We examined the modes by which DNA sequences evolve in human lineage-specific dREG-HD sites or DNase-I hypersensitive sites (DHSs) using INSIGHT 46 . We passed INSIGHT either complete DHSs, dREG-HD sites or TFBS within dREG-HD sites that undergo the changes (see 'Identifying differences in TREs between species') indicated in the comparison. Human gains and losses, for example, comprised 4,384 dREG-HD sites with 9,924 separate regions (median length: 16 bp) after merging overlapping TFBSs with a log-odds score greater than 10. We also analysed 24 transcription factors, each of which had more than 900 occurrences in dREG-HD sites that change on the human branch (log-odds score > 8). All analyses were conducted using the INSIGHT web server (http://compgen. cshl.edu/INSIGHT/) with the default settings enabled. bQTL analysis. Frequency shift estimates for all variants in ref. 63 were provided by the authors and converted to a queryable database filtered to include only variants with coverage by 25 reads (seventy-fifth percentile) or more to avoid noise at low read counts. For each sequence or variant query, a set of four equivalent sequences or alternate allele pairs was constructed by swapping which allele was the reference and obtaining the reverse complement for both alleles. For example, given a sequence:variant:position combination of AATCGAA:C:3, the other queries produced were AACCGAA:T:3 (allele swap), TTCGATT:G:5 (reverse complement) and TTCGGTT:A:5 (reverse complement allele swap). Frequency shifts were computed by taking the post-ChIP frequency minus the pre-ChIP frequency for the human reference allele. Since k-mers longer than 7 had few hits, we allowed for wildcards (N) in longer sequences that would match any base. Wildcards were introduced into a k-mer by matching the k-mer sequence to the NF-κ B motif and replacing the three lowest information content positions with N(s). Systematic shifts from zero were tested using a one-tailed t-test. P values for systematic differences at multiple sites were combined using Fisher's method.
De novo discovery of transcription units. Identification of transcription units using a three-state hidden Markov model. We inferred transcription units using a three-state hidden Markov model similar to those we have recently published 64, 65 . Each transcription unit begins at a TRE identified using dREG and continues through the entire region inferred to be transcribed, which can cover tens to hundreds of kilobases. Three states were used to represent background (that is, outside a transcription unit), the transcription unit body and a post-polyA decay region. The hidden Markov model transition structure is shown in Supplementary  Fig. 13a . We allow skipping over the post-polyA state, as unstable transcripts do not have these two-phase profiles. We took advantage of dREG as a potential signal for transcription initiation by incorporating the dREG score (maximum value in the interval from a given positive read-count position until the next, clamped to the zero-one interval) as a transition probability from the background to the transcription body state. PRO-Seq data are generally sparse, so we applied a transformation that encoded only non-zero positions and the distance between such consecutive positions ( Supplementary Fig. 13a ). Our model described these transformed data using emissions distributions based on two types of variable. The first type of emission variable defines the PRO-Seq read counts in nonzero positions. These counts were modelled using Poisson distributions in the background and post-polyA states, and using a negative binomial distribution in the transcription body state. The negative binomial distribution can be seen as a mixture of Poisson distributions with gamma-distributed rates and therefore allows for variation in transcription unit expression levels across the genome. The second type of emission variable describes the distribution of distances in base pairs between positions with non-zero read counts. This distribution was modelled using a separate geometric distribution for each of the three states. Maximum-likelihood estimates of all free parameters were obtained via expectation maximization on a per-chromosome basis. Transcription unit predictions were then obtained using the Viterbi algorithm with parameters fixed at their maximum-likelihood values. Finally, these predictions were mapped from the transformed coordinates back to genomic coordinates. Source code for our implementation is publicly available on GitHub: https://github.com/andrelmartins/tunits.nhp.
Inferring transcription unit boundaries in the common great ape ancestor. We identified the most likely transcription unit locations in the great ape ancestor by maximum parsimony. Transcription units were identified and compared in human reference coordinates (hg19) for all species. We used the bedops package to find the intersection between the predicted transcription unit intervals in each pair of species (that is, human-chimp, human-rhesus macaque and chimp-rhesus macaque). Intersections (≥ 1 bp) between pairs of species were merged resulting in a collection of transcription units shared by any two pairs of species and therefore likely to be a transcription unit in the human-chimp ancestor. All steps were applied independently on the plus and minus strands. These steps identified 37,626 putative transcription units active in CD4
+ T cells of the primate ancestor.
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We added 17,167 transcription units that did not overlap ancestral transcription units but were found in any one of the three primate species.
Transcription unit classification. transcription units were classified by annotation type using a pipeline similar to those we have described recently [64] [65] [66] . Before classifying transcription units, we applied a heuristic to refine transcription units on the basis of known annotations. Transcription units that completely overlap multiple gene annotations were broken at the TSS provided that a dREG site overlapped that TSS. Classification was completed using a set of rules to iteratively refine existing annotations, as shown in Supplementary Fig. 13a . Unless otherwise stated, overlap between a transcription unit and a transcript annotation was defined such that > 50% of a transcription unit matched a gene annotation and covered at least 50% of the same annotation. Transcription units overlapping GENCODE annotations (> 50% overlap, defined as above) were classified using the biotype in the GENCODE database into protein coding, long intergenic non-coding RNA (long intergenic non-coding RNA or processed transcript) or pseudogene. The remaining transcripts were classified as annotated RNA genes using GENCODE annotations, the rnaGenes UCSC Genome Browser track (converted from hg18 to hg19 coordinates) and miRBase version 20 (ref. 67 ). As many RNA genes are processed from much longer transcription units, we required no specific degree of overlap for RNA genes. Upstream antisense (that is, divergent) transcription units were classified as those within 500 bp of the TSS of any GENCODE or higher level transcription unit annotation (including long intergenic non-coding RNAs). Antisense transcripts were defined as those with a high degree of overlap (> 50%) with annotated protein-coding genes in the opposite orientation. The remaining transcripts with a high degree of overlap (> 50%) to annotated repeats in the repeatmasker database were classified as repeat transcription. Finally, any transcription units still remaining were classified as unannotated and were further divided into those that are intergenic and those that partially overlap existing annotations.
Comparing transcription between conditions and species. Comparing transcription before and after CD4
+ T cell activation. We compared PMA and ionomycin-treated and untreated CD4 + T cells within each of the primate species using gene annotations (GENCODE version 19). We focused on 42,556 GENCODE-annotated transcription units best supported by PRO-Seq data for human CD4 + T cells using tuSelector 68 . We counted reads in the interval between 500 bp downstream of the annotated TSS and either the end of the gene or 60,000 bp into the gene body (whichever was shorter). This window was selected (1) to avoid counting reads in the pause peak near the TSS and (2) to focus on the 5′ end of the gene body affected by changes in transcription during 30 min of PMA and ionomycin treatment assuming a median elongation rate of 2 kb min -1 (refs 64, 69 ). We limited analyses to gene annotations longer than 500 bp in length. To quantify transcription at enhancers, we counted reads in the window covered by each dREG-HD site plus an additional 250 bp on each end. Differential expression analysis was conducted using DESeq2 (ref. 43 ).
Comparing transcription between species. Read counts were compared between different species in hg19 coordinates. In all analyses, reads were transferred to the hg19 reference genome using CrossMap with rbest nets. Our analysis focused on transcription units or the union of dREG sites across species. We focused our analysis of transcription units on the interval between 250 bp downstream of the annotated TSS and either the end of the gene or 60,000 bp into the gene body (whichever was shorter). We limited our analyses to transcription units longer than 500 bp in length. Reads counts were obtained within each transcription unit, gene annotation or enhancer, abbreviated here as a 'region of interest' (ROI), that has confident one-to-one orthology in all species examined in the analysis. This strategy of focusing on blocks of one-to-one orthology avoids errors caused by systematic differences in mappability or repeat content of species-specific genomic segments. We broke each ROI into segments with conserved orthology between hg19 and all species examined in the analysis, which included either a three-way (human-chimp-rhesus macaque) or five-way (human-chimp-rhesus macaquemouse-rat) species comparison. We defined intervals of one-to-one orthology as those represented in levels 1, 3 and 5 of the rbest nets (with gaps defined in levels 2, 4 and 6) 53 . Reads that map to regions that have orthology defined in all species were counted using the bigWig package in R using reads mapped to hg19 coordinates. Final counts for each ROI were defined as the sum of read counts within the regions of orthology that intersect that ROI. ROIs without confident one-to-one orthologues in all species analysed were discarded. Our pipeline makes extensive use of the bigWig R package, Kent source tools, as well as the bedops and bedtools software packages 50, 70 . Differential expression was conducted between species using the DESeq2 package for R, as described above.
MCF-7 G11 cell culture. Analysis of PRO-Seq data in MCF-7 cells 71 revealed a similar pattern of transcription at the SGPP2 locus ( Supplementary Fig. 10 ). The MCF-7 G11 tamoxifen-resistant cells were a gift from J. LaBaer. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 5% FBS, antibiotics and 1 μ M tamoxifen. MCF-7 G11 dCas9-KRAB stable cell lines were made (as described below) and were maintained in DMEM with 5% FBS, antibiotics and 1 μ M tamoxifen. MCF-7 G11 dCas9-KRAB sgRNA stable cell lines were maintained in DMEM with 5% FBS, antibiotics 1 μ M tamoxifen and 150 μ g ul -1 Hygromycin B.
Luciferase assays. Genomic DNA was isolated from human, chimp and rhesus macaque peripheral blood mononuclear cells depleted for CD4 + cells using a Quick-DNA Miniprep Plus Kit (#D4068S; Zymo Research) following the manufacturer's instructions. Putative enhancer regions were amplified from the genomic DNA, restriction digested with KpnI and MluI, and cloned into the pGL3-promoter vector (Promega). The same orthologous regions were amplified from all three species with identical primers where possible or species-specific primers covering orthologous DNA in diverged regions. Vectors were cotransfected with pRL-SV40 Renilla (Promega) in a 10:1 ratio (500 ng pGL3 to 50 ng pRL-SV40) in MCF-7 G11 cells cultured in 1 μ M tamoxifen. Transfected cells were treated with either 25 ng ml -1 TNFα or water 21 h after transfection. Then, 24 h post-transfection, luminescence was measured in triplicate using the Dual-Luciferase Reporter Assay System (Promega).
Silencing endogenous TREs using dCAS9-KRAB. Cloning sgRNAs. We used CRISPR interference to silence enhancers near SGPP2 (ref. 72 ). sgRNAs were designed using the CRISPR design tool (http://crispr.mit.edu) and the sequences are shown in Supplementary Table 3 . Forward and reverse sgRNAs were synthesized separately by Integrated DNA technologies (IDT) and annealed. T4 Polynucleotide Kinase (NEB) was used to phosphorylate the forward and reverse sgRNA during the annealing. 10× T4 DNA Ligase Buffer, which contains 1 mM adenosine triphosphate, was incubated for 30 min at 37 °C and then at 95 C for 5 min, decreasing by 5 °C every 1 min until 25 °C was reached. Oligos were diluted 1:200 using Molecular Grade Water. sgRNAs were inserted into the pLenti SpBsmBI sgRNA Hygro plasmid from Addgene (#62205) by following the authors' protocol 73 . The plasmid was linearized using BsmBI digestion (NEB) and purified using gel extraction (QIAquick Gel Extraction Kit). The purified linear plasmid was then dephosphorylated using Alkaline Phosphatase Calf, Intestinal (CIP) (NEB) to ensure the linear plasmid did not ligate with itself. A second gel extraction was used as before to purify the linearized plasmid. The purified dephosphorylated linear plasmid and phosphorylated annealed oligos were ligated together using the Quick Ligation Kit (NEB). The ligated product was transformed into One Shot Stbl3 Chemically Competent E. coli (Thermo Fisher Scientific). 100 ul of the transformed bacteria were plated on ampicillin (200 μ g ml -1 ) plates. Single colonies were picked and sequenced, and the plasmid was isolated using Endo-Free midipreps from Omega.
Transfection of MCF-7 G11 cell lines. We used lentivirus to transfect MCF-7 cells. Lentivirus was made using Lipofectamine 3000 from Invitrogen. Phoenix Hek cells (grown in DMEM with 10% FBS and antibiotics) were seeded in a 6-well plate at 400,000 cells plate -1 . Cells were grown until ~90% confluent. Then, 1 μ g of pHAGE_EF1a_dCas9-KRAB plasmid from Addgene (#50919) or the pLenti SpBsmBI sgRNA Hygro (Addgene #62205) containing each sgRNA, 0.5 μ g of psPAX (Addgene #12260) and 0.25 μ g pMD2.G (Addgene #12259) were mixed.
MCF-7 G11 cells were plated at ~200,000 cells well -1 in a 6-well plate. Then, 24 h later, 3 ml well -1 of virus was mixed with 10 μ g ml -1 polybrene and incubated for 5 min at room temperature. This mix was added to the cells and centrifuged for 40 min at 800 g at 32 ºC. Some 12-24 h later, the virus was removed and fresh media was added. Another 24-48 h later, the cells were selected with 2 μ g ml -1 puromycin for 2 weeks. The MCF-7 G11 dCas9-KRAB stable cell lines were grown and maintained in puromycin. A second lentiviral infection was initiated using the stable MCF-7 G11 dCas9-KRAB cells. The same protocol was used. Then, 24-48 h later, the cells were selected with 150 μ g ml -1 Hygromycin B. New stable cell lines were grown and maintained in Hygromycin B.
TNFα treatment. Before TNFα treatment, cells were grown for three days in DMEM with 5% FBS, antibiotics, tamoxifen and hygromycin. Cells were then left untreated or treated for 40 min with 25 ng ml -1 TNFα . RNA was extracted using TRIzol Reagent (Invitrogen). We reverse transcribed 1 μ g of RNA and used this as input for real-time quantitative polymerase chain reaction to analyse SGPP2 expression. Primers for SGPP2 were designed targeting a sequence in intron 1 upstream of the intronic enhancer. Raw cross point cycle (Cp) values were transferred to units of expression using a standard dilution curve comprising a mixture of complementary DNA from each sample within the biological replicate. We included four serial dilutions, each of which covered a twofold difference in expression. Each sample was further normalized for differences in RNA content by primers recognizing the 18S ribosomal RNA control. The ratio between normalized SGPP2 expression in each sgRNA-transfected MCF-7 cell line and the empty vector control was log 2 -transformed and tested for differences from 0 using a two-sided t-test.
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Experimental design
Sample size
Describe how sample size was determined.
No specific statistical power test was conducted. Three individuals were selected to represent each species to account for within-species variation, and provides enough statistical power to identify medium-sized differences between species.
Data exclusions
Describe any data exclusions. We required that the estimated library complexity for the total number of uniquely mappable reads was >30M in each PRO-seq library. This exclusion criteria removed one dataset for each species and condition from detailed analysis.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication of experimental findings were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were allocated to groups based on the species from which each sample was derived. Each sample was split in two and treated or left untreated with PMA and Ionomycin.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Not really applicable. It was not possible to blind the species or condition during data processing or analysis.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
